Neuroendocrine Tumors, NET
5 clinical trials · Condition
◉ Watch Neuroendocrine Tumors, NET
| Record | Firm | Date |
|---|---|---|
| A Comparison of [68Ga]DOTATATE and [18F]AmBF3TATE for the Staging and Assessment of Neuroendocrine Malignancies (NCT07621146) | British Columbia Cancer Agency | 2026-09-15 |
| Management of Pancreatic Cystic Lesions Using Artificial Intelligence Based on EUS and Multimodal Data (NCT07463872) | Huazhong University of Science and Technology | 2025-01-01 |
| 68Ga-HA-DOTATATE PET/CT in Adults With Neuroendocrine Tumors (NCT05673031) | Alberta Health services | 2023-02-01 |
| A Transfer Learning Radiomics Model for Predicting Response to Initial Transarterial Embolization in Patients with Gastroenteropancreatic Neuroendocrine Tumor Liver Metastases (NCT06853457) | First Affiliated Hospital, Sun Yat-Sen University | 2014-01-01 |
| Review of Medical Records of Patients Who Have Been Treated With Lutetium at the Cross Cancer Institute Between January 2010 and April 30, 2014 (NCT01763554) | AHS Cancer Control Alberta | 2012-08-01 |
Track Neuroendocrine Tumors, NET automatically
Every clearance here is in the API, with alerts when new ones post.